MYRIAD GENETICS INC
10-K, EX-27, 2000-09-13
COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
Previous: MYRIAD GENETICS INC, 10-K, EX-23.1, 2000-09-13
Next: SIGNAL TECHNOLOGY CORP, 8-K, 2000-09-13



<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM CONSOLIDATED
STATEMENTS OF OPERATIONS AND CONSOLIDATED BALANCE SHEETS AND IS QUALIFIED IN ITS
ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>

<S>                             <C>
<PERIOD-TYPE>                   12-MOS
<FISCAL-YEAR-END>                          JUN-30-2000
<PERIOD-START>                             JUL-01-1999
<PERIOD-END>                               JUN-30-2000
<CASH>                                      56,214,736
<SECURITIES>                                32,441,108
<RECEIVABLES>                                2,497,154
<ALLOWANCES>                                   145,000
<INVENTORY>                                          0
<CURRENT-ASSETS>                            85,931,776
<PP&E>                                      20,971,274
<DEPRECIATION>                               9,719,556
<TOTAL-ASSETS>                             106,375,305
<CURRENT-LIABILITIES>                       28,668,658
<BONDS>                                              0
                                0
                                          0
<COMMON>                                       218,666
<OTHER-SE>                                  77,487,981
<TOTAL-LIABILITY-AND-EQUITY>               106,375,305
<SALES>                                      8,793,272
<TOTAL-REVENUES>                            34,013,038
<CGS>                                        3,986,473
<TOTAL-COSTS>                               45,560,165
<OTHER-EXPENSES>                               383,481
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                            (8,722,102)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                        (8,722,102)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                               (8,722,102)
<EPS-BASIC>                                      (.43)
<EPS-DILUTED>                                    (.43)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission